Current immunosuppression in liver transplantation.
Liver transplantation has emerged from an experimental therapy to a highly successful treatment for end-stage liver disease. The single most important factor in this progression has been the development of effective immunosuppressive regimens. This article will outline the various immunosuppressive agents used in liver transplantation.
Cohen
Stanley Martin
SM
Liver Study Unit, University of Chicago Medical Center, Chicago, Illinois 60637, USA. mcohen@medicine.bsd.uchicago.edu.
D000961:Antilymphocyte Serum; D001379:Azathioprine; D065095:Calcineurin Inhibitors; D016572:Cyclosporine; D006801:Humans; D007166:Immunosuppressive Agents; D016031:Liver Transplantation; D016853:Muromonab-CD3; D009173:Mycophenolic Acid / Q000031:analogs & derivatives*; D015375:Receptors, Interleukin-2 / Q000037:antagonists & inhibitors; D020123:Sirolimus; D016559:Tacrolimus
D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D020123:Sirolimus; D016559:Tacrolimus